The Valley Desk

NCT02606136 · Interventional trial

Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Overall registry status Terminated

Phase 2

Conditions Duchenne Muscular Dystrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov